What Is The Best Time Sampling For The Two Direct Oral Anticoagulants, Dabigatran and Rivaroxaban?

被引：0
|
作者：
Douxfils, Jonathan
Classen, Jean-Francois
Baudar, Justine
Devalet, Berangere
Samama, Meyer Michel
Chatelain, Bernard
Dogne, Jean-Michel
Mullier, Francois
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4805
引用
收藏
页数：2
相关论文
共 50 条
  • [1] What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?
    Douxfils, J.
    Baudar, J.
    Devalet, B.
    Samama, M. M.
    Chatelain, B.
    Dogne, J-M
    Mullier, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 9 - 10
  • [2] Direct oral anticoagulants (DOACs) - dabigatran, rivaroxaban, apixaban, edoxaban - addition - EML
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 339 - 355
  • [3] Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
    Yin, Lu
    Qi, Yuan
    Ge, Zhiru
    Li, Jiajin
    OPEN LIFE SCIENCES, 2022, 17 (01): : 1 - 9
  • [4] Novel Oral Anticoagulants in Development: Dabigatran, Rivaroxaban, and Apixaban
    Sattari, Maryam
    Lowenthal, David T.
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (04) : 332 - 338
  • [5] Laboratory monitoring of novel oral anticoagulants rivaroxaban and dabigatran
    Eerenberg, E. S.
    Kamphuisen, P. W.
    Sijpkens, M. K.
    Meijers, J. C.
    Buller, H. R.
    Levi, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 956 - 956
  • [6] Real-time detection and differentiation of direct oral anticoagulants (rivaroxaban and dabigatran) using modified thromboelastometric reagents
    Schafer, Simon Thomas
    Wiederkehr, Tobias
    Kammerer, Tobias
    Acevedo, Alice-Christin
    Feil, Katharina
    Kellert, Lars
    Goerlinger, Klaus
    Hinske, Ludwig Christian
    Groene, Philipp
    THROMBOSIS RESEARCH, 2020, 190 : 103 - 111
  • [7] Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran
    Al-Ghafry, Maha
    Sharathkumar, Anjali
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [8] EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS DABIGATRAN, RIVAROXABAN AND APIXABAN
    Elnadoury, Ola
    Yuen, Meggie
    Oh, Erin
    Abraham, Teena
    Saad, Nasser
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [9] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Heard, L. Kevin
    Shanahan, Christine
    Maggio, Kurt L.
    DERMATOLOGIC SURGERY, 2017, 43 (04) : 597 - 599
  • [10] Complications With New Oral Anticoagulants Dabigatran and Rivaroxaban in Cutaneous Surgery
    Chang, Timothy W.
    Arpey, Christopher J.
    Baum, Christian L.
    Brewer, Jerry D.
    Hochwalt, Phillip C.
    Hocker, Thomas L.
    Roenigk, Randall K.
    Otley, Clark C.
    DERMATOLOGIC SURGERY, 2015, 41 (07) : 784 - 793
12345